Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

To detect and characterize autoreactive T cells in diabetes-prone NOD mice, we have developed a multimeric MHC reagent with high affinity for the BDC-2.5 T cell receptor, which is reactive against a pancreatic autoantigen. A distinct population of T cells is detected in NOD mice that recognizes the same MHC/peptide target. These T cells are positively selected in the thymus at a surprisingly high frequency and exported to the periphery. They are activated specifically in the pancreatic LNs, demonstrating an autoimmune specificity that recapitulates that of the BDC-2.5 cell. These phenomena are also observed in mouse lines that share with NOD the H-2g7 MHC haplotype but carry diabetes-resistance background genes. Thus, a susceptible haplotype at the MHC seems to be the only element required for the selection and emergence of autoreactive T cells, without requiring other diabetogenic loci from the NOD genome.

[1]  Mark M. Davis,et al.  LIGAND RECOGNITION BY T CELL RECEPTORS , 1998 .

[2]  D G Myszka,et al.  Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. , 1997, Methods in enzymology.

[3]  Troy Krahl,et al.  Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry , 1998, Nature Medicine.

[4]  O. Pankewycz,et al.  Islet‐infiltrating T cell clones from non‐obese diabetic mice that promote or prevent accelerated onset diabetes , 1991, European journal of immunology.

[5]  R. Döffinger,et al.  Tolerance and immunity to the inducible self antigen C‐reactive protein in transgenic mice , 1995, European journal of immunology.

[6]  C. Benoist,et al.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. McGavern,et al.  Molecular anatomy of antigen-specific CD8+ T cell engagement and synapse formation in vivo , 2002, Nature Immunology.

[8]  H. Kikutani,et al.  T cell receptor V gene usage of islet beta cell-reactive T cells is not restricted in non-obese diabetic mice , 1991, The Journal of experimental medicine.

[9]  B. Bergman,et al.  Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. , 1994, Diabetes.

[10]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[11]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.

[12]  K. Haskins,et al.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.

[13]  T. Schumacher,et al.  In situ detection of virus- and tumor-specific T-cell immunity , 2000, Nature Medicine.

[14]  Rustom Antia,et al.  Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.

[15]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[16]  Clemencia Pinilla,et al.  Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1 , 2001, The Journal of Immunology.

[17]  P. Marrack,et al.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. , 1998, Immunity.

[18]  M. Bevan,et al.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.

[19]  M. Dorf,et al.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.

[20]  K. Wucherpfennig,et al.  Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes , 2000, European journal of immunology.

[21]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[22]  H. Rammensee,et al.  Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. , 2002, International immunology.

[23]  Genetic control of specific immune responses. , 1969, Advances in immunology.

[24]  J. Todd,et al.  Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. , 2001, Immunity.

[25]  K. Garcia,et al.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules , 1996, The Journal of experimental medicine.

[26]  L R Pease,et al.  Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Sprent,et al.  A defect in central tolerance in NOD mice , 2001, Nature Immunology.

[28]  V. Apostolopoulos,et al.  The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder1 , 2000, The Journal of Immunology.

[29]  J. Todd,et al.  Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.

[30]  B. Bergman,et al.  Islet-Specific T-Cell Clones From the NOD Mouse Respond to β-Granule Antigen , 1994, Diabetes.

[31]  C. Benoist,et al.  Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes , 1999, The Journal of experimental medicine.

[32]  P. Schatz.  Use of Peptide Libraries to Map the Substrate Specificity of a Peptide-Modifying Enzyme: A 13 Residue Consensus Peptide Specifies Biotinylation in Escherichia coli , 1993, Bio/Technology.

[33]  C. Benoist,et al.  Delineation of antigen contact residues on an MHC class II molecule. , 1990, The EMBO journal.

[34]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[35]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[36]  Emmanuel Beaudoing,et al.  Size Estimate of the αβ TCR Repertoire of Naive Mouse Splenocytes1 , 2000, The Journal of Immunology.

[37]  E. Unanue,et al.  Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Fraire,et al.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung , 2001, Nature Immunology.

[39]  H. Boehmer,et al.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes , 1988, Nature.

[40]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.

[41]  M. Mattéi,et al.  Genetic control of diabetes progression. , 1997, Immunity.

[42]  G. Nepom,et al.  Molecular basis for HLA-DQ associations with IDDM. , 1998, Diabetes.

[43]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[44]  K. Lafferty,et al.  Pancreatic islet-specific T-cell clones from nonobese diabetic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[46]  H. Pircher,et al.  Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts , 1996, The Journal of experimental medicine.

[47]  C. Benoist,et al.  Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.

[48]  K. Gabbay,et al.  The Search for IDDM Susceptibility Genes: The Next Generation , 1996, Diabetes.

[49]  P. Santamaria,et al.  In Situ β Cell Death Promotes Priming of Diabetogenic CD8 T Lymphocytes1 , 2002, The Journal of Immunology.

[50]  W. Ridgway,et al.  A New Look at MHC and Autoimmune Disease , 1999, Science.

[51]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[52]  D. Fremont,et al.  Molecular Basis for Recognition of an Arthritic Peptide and a Foreign Epitope on Distinct MHC Molecules by a Single TCR1 , 2000, The Journal of Immunology.

[53]  L. Wen,et al.  Human DQ8 Can Substitute for Murine I-Ag7 in the Selection of Diabetogenic T Cells Restricted to I-Ag71 , 2002, The Journal of Immunology.

[54]  C. Benoist,et al.  Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes , 2001, Nature Immunology.

[55]  D. Wegmann,et al.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.

[56]  C. Benoist,et al.  Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[58]  J. Casanova,et al.  Antigen-selected T-cell receptor diversity and self-nonself homology. , 1993, Immunology today.

[59]  B. Woda,et al.  NOD mice have a generalized defect in their response to transplantation tolerance induction. , 1999, Diabetes.

[60]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[61]  N. Sarvetnick,et al.  The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes. , 2000, Clinical immunology.

[62]  H. Mcdevitt,et al.  The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Haase,et al.  Cutting Edge: In Situ Tetramer Staining of Antigen-Specific T Cells in Tissues1 , 2000, The Journal of Immunology.

[64]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[65]  E. Sercarz,et al.  Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. , 1993, Journal of immunology.

[66]  E. Unanue,et al.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.

[67]  C. Pinilla,et al.  Detection and Characterization of T Cells Specific for BDC2.5 T Cell-Stimulating Peptides1 , 2003, The Journal of Immunology.

[68]  J. Todd,et al.  Genetic analysis of autoimmune disease: a review , 1996 .

[69]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[70]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[71]  Bhagirath Singh,et al.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.

[72]  R B Smith,et al.  Insulin dependent diabetes mellitus. , 1992, The New Zealand medical journal.

[73]  Jingwu Z. Zhang,et al.  Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity , 1992, Annals of neurology.

[74]  P. Santamaria,et al.  In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. , 2002, Journal of immunology.

[75]  H. Mcdevitt,et al.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.